SLC16A3 and diffuse large B-cell lymphoma: Farage, Pfeiffer, RIVA, Toledo and WSU-DLCL2 DLBCL cell lines were selected based on their previously defined MCT1+/MCT4− protein expression and known sensitivity to AZD3965 [6, 12].